Cargando…
On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships
Functional human-on-a-chip systems hold great promise to enable quantitative translation to in vivo outcomes. Here, we explored this concept using a pumpless heart only and heart:liver system to evaluate the temporal pharmacokinetic/pharmacodynamic (PKPD) relationship for terfenadine. There was a ti...
Autores principales: | McAleer, Christopher W., Pointon, Amy, Long, Christopher J., Brighton, Rocky L., Wilkin, Benjamin D., Bridges, L. Richard, Narasimhan Sriram, Narasimham, Fabre, Kristin, McDougall, Robin, Muse, Victorine P., Mettetal, Jerome T., Srivastava, Abhishek, Williams, Dominic, Schnepper, Mark T., Roles, Jeff L., Shuler, Michael L., Hickman, James J., Ewart, Lorna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610665/ https://www.ncbi.nlm.nih.gov/pubmed/31270362 http://dx.doi.org/10.1038/s41598-019-45656-4 |
Ejemplares similares
-
Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation
por: Slaughter, Victoria L., et al.
Publicado: (2021) -
Development of a human malaria-on-a-chip disease model for drug efficacy and off-target toxicity evaluation
por: Rupar, Michael J., et al.
Publicado: (2023) -
Differential Monocyte Actuation in a Three‐Organ Functional Innate Immune System‐on‐a‐Chip
por: Sasserath, Trevor, et al.
Publicado: (2020) -
Microphysiological systems and low-cost microfluidic platform with analytics
por: Smith, Alec ST, et al.
Publicado: (2013) -
Elevated serum beta-hCG due to a tumour of unknown origin.
por: Kenny, L., et al.
Publicado: (2004)